Kimberly Gentile
2019
Compensation breakdown
| Bonus | $228,042 |
|---|---|
| Option Awards | $1,205,401 |
| Salary | $372,313 |
| Stock Awards | $861,000 |
| Other | $13,734 |
| Total | $2,680,490 |
Gentile received $1.2M in option awards, accounting for 45% of the total pay in 2019.
Gentile also received $228K in bonus, $372.3K in salary, $861K in stock awards and $13.7K in other compensation.
Rankings
In 2019, Kimberly Gentile's compensation ranked 4,555th out of 13,971 executives tracked by ExecPay. In other words, Gentile earned more than 67.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,555 out of 13,971 | 67th |
Division Manufacturing | 1,702 out of 5,692 | 70th |
Major group Chemicals And Allied Products | 595 out of 2,189 | 73rd |
Industry group Drugs | 501 out of 1,875 | 73rd |
Industry Pharmaceutical Preparations | 378 out of 1,387 | 73rd |
Pay ratio
| Kimberly Gentile's Pay | $2,680,490 |
|---|---|
| Median Employee's Pay | $165,840 |
| Pay Ratio | 16to 1 |
In 2019, the annual total compensation of Kimberly Gentile was $2,680,490.
The annual total compensation of the median employee at Biohaven Pharmaceutical Holding Co Ltd. was $165,840.
The ratio of Kimberly Gentile's pay to the pay of median employee was therefore 16 to one.
Gentile's colleagues
We found four more compensation records of executives who worked with Kimberly Gentile at Biohaven Pharmaceutical Holding Co Ltd. in 2019.
2019
Vlad Coric
Biohaven Pharmaceutical Holding Co Ltd.
Chief Executive Officer
2019
William Jones
Biohaven Pharmaceutical Holding Co Ltd.
Chief Commercial Officer of Migraine & Common Diseases
2019
James Engelhart
Biohaven Pharmaceutical Holding Co Ltd.
Chief Financial Officer
2019
Elyse Stock
Biohaven Pharmaceutical Holding Co Ltd.